Background: Many studies have linked depression to an increase in the excitatory-
Introduction
Abnormalities in glutamate and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular mechanisms (1, 2) .
Using magnetic resonance spectroscopy, increased glutamate and reduced GABA levels have been observed in the cortex of depressed patients leading to an enhanced excitatory-inhibitory ratio (3) (4) (5) (6) (7) . Interestingly, this imbalance is particularly associated with melancholic features in the patients (5) and is reverted by chronic treatment with antidepressants (8) . Since the presynaptic pathways regulating the synthesis and cycling of glutamate and GABA are tightly coupled, it has been suggested that alterations in a shared pathway may account for the observed amino acid abnormalities. For instance, microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depression disorder have demonstrated significant down-regulation of the glial EAAT1 and EAAT2, key members of the glutamate/neutral amino acid transporter protein family (9) . Other post-mortem studies have shown decreased expression of GAD 65 and 67, the enzymes that convert glutamate to GABA, in mood disorders (10) (11) . Altogether, these changes could limit GABA synthesis and elevate levels of extracellular glutamate, which in turn, could affect the efficiency of signaling by both neurotransmitters.
At the experimental level, the vesicular glutamate transporter 1 (VGLUT1) has been reported to play a key role in the synaptic release (12) and the efficacy of glutamatergic synaptic transmission (13) (14) (15) (16) . A recent study carried out in our laboratory reports that mice heterozygous for VGLUT1 (VGLUT1+/-), exhibit decreased cortical and hippocampal levels (35-45 %) of the inhibitory neurotransmitter GABA as well as helplessness in the forced swimming test (17) . Here, we asked whether decreased VGLUT1 levels could be considered as a potential biological risk factor of major depression, alone and in combination with adverse environmental factors. Firstly, neuronal versus glial glutamate and GABA synthesis as well as oxidative metabolism, which is highly regulated by glutamatergic neurotransmission (18, 19) was studied by 13 C magnetic resonance spectroscopy ( 13 C-MRS) and cytochrome oxidase histochemistry respectively. Secondly, we studied how neurotransmitter levels, the expression of presynaptic proteins involved in the glutamate/GABA cycle as well as behaviour could be influenced by genotype (VGLUT1+/-mice), the environmental model of depression chronic mild stress (CMS) and by the interaction between both. Finally, we asked whether repeated treatment with the antidepressant imipramine was able to revert the behavioural deficit induced by CMS in the VGLUT1+/-mice.
Methods and Materials

Animals
Heterozygous VGLUT1 male mice (VGLUT1+/-) C57BL⁄6N were bred from heterozygous fathers (Dr S. Wojcik, Gottingen, Germany) and WT mothers (Harlan, France). The VGLUT1-/-knock-out allele was generated by truncation of the coding region of the VGLUT1 gene between the start codon and a BglII site in the fifth coding exon through homologous recombination in embryonic stem cells (129/ola background) (13) . These mice show a progressive neuropathological phenotype and increased lethality rate at 2-3 weeks after birth.
Experimental procedures and animal husbandry were conducted according to principles of laboratory animal care as detailed in the European Communities Council Directive Committee (University of Navarra).
C-MRS Spectroscopy
A previously protocol described (20) Twenty minutes later, mice were decapitated, the heads snap frozen in liquid nitrogen and kept at -80 ºC. Brains were removed from the skull while frozen and, after discarding the cerebellum, homogenized with 600 µL of perchloric acid (7% vol/vol). Protein was removed by centrifugation (7,500 rpm; 6 min). Aliquot (5 μl) from the supernatant were reserved for HPLC measurement of the concentration of metabolites, and the rest neutralized with 1 M KOH followed by lyophilisation. Lyophilizates were dissolved in 400 µL D 2 O containing 0.1% of ethylene glycol (vol/vol) as an internal standard. Proton decoupled 13 C-MRS spectra were obtained using a Bruker DRX-400 spectrometer (Bruker Analytik GmbH, Germany) and the number of scans was 25,000.
Metabolites derived from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose and [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate represent the contribution from neurons and astrocytes to glutamate, glutamine and GABA formation respectively (20) .
Cytochrome C oxydase histochemistry
WT and VGLUT1 mice (n=10/group) were decapitated, brains removed, immediately frozen and stored (−80 °C). Coronal sections (50 μm) were used for the staining procedure, as described previously (21) with minor modifications (22). Stained sections were photographed with a Nikon Coolpix 5400 digital camera mounted on a Nikon SMZ 1000 stereomicroscope. Image analysis of one hundred regions of interest (ROI) was conducted using the Image J1.39 freeware.
Neurotransmitter brain levels
GABA and glutamate concetrations in frontal cortex and hippocampus from CMS and control mice (WT and VGLUT1+/-) (n=15 mice/group) were determined by HPLC with electrochemical detection (DECADE, Antec-Leyden). A high sensitivity analytical flowcell (VT-03) was used and the working electrode was set at 0.7 V. A column (Biophase ODS 5 μm, 4.6mm×150 mm) including precolumn derivatization with o-phthaldehyde and β-mercapthoethanol (Sigma-Aldrich Ltd., Germany) was used. Results were expressed in ng per mg of wet tissue.
Western blotting
Cortical and hippocampal expression of different proteins involved in the glutamate/GABA cycle were studied by Western blotting using the following primary antibodies: rabbitt anti-VGLUT1 (1:2,000) (donated by Dr S. El Mestikawy, Paris, France), mouse anti-VGLUT2
(1:1,000) and rabbit anti-VGAT (1:1,000) (Chemicon Int., CA, USA), mouse anti-GAD65
(1:5,000) (Abcam, Cambridge, UK) and rabbitt anti-EAAT1 and EAAT2 (1:2500) (Santa Cruz, UK). Horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse secondary antibodies (DAKO, U.K. 1:10,000) were used followed by visualization through chemiluminescence using SuperSignal West Pico (Pierce Biotechnology). Films were scanned and quantified using the ImageMaster 1D (Pharmacia Biotech, Sweden)
software and normalised to β-actine.
Chronic mild stress (CMS) procedure
Unpredictable repeated mild stressors were applied for six weeks (23). In the first experiment CMS was applied to WT and VGLUT+/-mice (n=15 mice/group) and both control and stressed mice were sacrificed 24 h after the termination of CMS.
In the second experiment, the effect of repeated imipramine treatment on different behavioural paradigms was studied in control and CMS VGLUT1+/-mice. Imipramine HCl (10 mg/kg i.p. Sigma-Aldrich) or saline were administered daily the last 3 weeks of the CMS and continued for one week thereafter.
Over the last week of CMS (first experiment) and over the week immediately after the CMS (second experiment) a battery of behavioural tests was performed.
Behavioural tests
Sucrose intake test
Anhedonic-like behaviour was evaluated during the CMS procedure by weekly monitoring of sucrose intake (24). Mice were firstly trained to drink the sucrose solution during one week and during the procedure were given once a week a 15-h exposure to the sucrose solution and tap water. Body weight measurements were taken weekly and relative sucrose intake and sucrose preference (sucrose intake/total intake) was calculated as absolute intake (g) per weight.
Spontaneous locomotor activity
Locomotor activity was measured in an open field consisting of 9 black arenas (43 x 50 x 45) using a video tracking system (Ethovision XT, Noldus Information Technology B. V., Wageningen, The Netherlands) in a softly illuminated room. One mouse was placed in each cage and distance travelled (cm) was recorded during a 30 min period.
Forced swimming test
The forced swimming test is the most widely used test of depression in rodents. Mice were individually placed into glass cylinders (height 24 cm, diameter 13 cm) containing water (14 cm, 22-23°C). Immobility, indicative of helpless behaviour, was recorded during the last 4 min of the 6 min testing period and is considered a measure of helpless behaviour.
Elevated-plus maze (EPM)
This test was applied to measure unconditioned anxiety-like behaviour. 
Marble Burying test
Compulsive-anxiety behaviour in mice was assessed by this test (25). Eight marbles (1.5 cm diameter) were placed uniformly in a cage (45 × 28 × 20 cm) containing a constant amount of sawdust (3 cm deep). Mice were placed in the center of the cage and left for 30 minutes. The number of marbles buried was recorded.
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Novel object recognition
Visual recognition memory was assessed by this test (23). The apparatus consisted of a black square arena (43 x 50 x 45 cm). On day 1, mice were placed for 30 min in the arena to habituate them. On day 2, mice were placed in the box at equal distance from two identical objects (A1 and A2; two prisms 7 x 3 x 3 cm) for 5 min (sample phase). One hour after, mice were placed back in the box and exposed to a familiar object (A3) and to a novel object (B; a ball of 3.5 cm of diameter mounted on a cube of 3 cm 
Statistical analysis
The effect of genotype in the spectroscopy and histochemistry studies was analyzed by using Student's t-test.
Neurotransmitter levels and protein expressions were analyzed with two-way ANOVA (stress × genotype). Different parameters of the behavioral test were analyzed using twoway ANOVA (stress × genotype for the first experiment and stress × treatment for the second). Significant main effects or interactions were analyzed using Student t-test.
Sucrose intake was analyzed with two-way ANOVA with repeated measures followed by two way ANOVA for each week. (Table 1A) .
Results
Neuronal
However, no changes in the levels of the other metabolites were detected between the two groups. Similarly, acetate/glucose utilization ratios for glutamate, glutamine and GABA were not altered (Table 1B) .
Cytochrome C oxydase activity
Pair-wise comparison of optical density values in VGLUT1+/-and WT mice for each of the 100 ROIs produced no significant differences. Interestingly, in almost all brain regions the VGLUT+/-mice showed a slight non-significant increase of activity.
Neurotransmitter brain levels
There was no interaction between genotype and stress in glutamate levels either in frontal cortex or in hippocampus. However, a significant effect of stress in both brain and hippocampal (74 % of WT for control VGLUT1+/-mice) EAAT1 expression. CMS induced a significant increase of EAAT1 in the WT mice (~159 %) in the hippocampus compared to WT. (Figure 3E ).
The expression of EAAT2 in the cortex and hippocampus was not altered neither by stress nor genotype ( Figure 3F ). ( Figure 4A-B) . On the sixth week, CMS induced a higher decrease in sucrose intake in VGLUT1+/-than in WT mice.
Sucrose intake
Secondly, the effect of repeated treatment of imipramine on the decrease of sucrose intake induced by CMS in the VGLUT1+/-mice was studied. We found no interaction between sucrose intake, stress and treatment [ On the other hand, no major differences were detected in sucrose preference (sucrose intake/total intake) among the groups (data not shown). In the second experiment, we found no interaction between stress and imipramine treatment. In addition, no effects either of stress or treatment were shown ( Figure 5C ).
Marble burying
Marble burying behaviour was not affected either by CMS or by genotype. Similarly, Neither stress nor imipramine treatment altered this behaviour. (Data not shown).
Novel object recognition
Recognition memory was impaired by CMS. No interaction between genotype and stress on discriminating new and familiar objects was shown. CMS induced a decrease in discrimination index one hour after the sample phase [F 1,56 = 16.596, p<0.01] in both WT and VGLUT1+/-mice. (Figure 4E ).
In the second experiment, a significant interaction between imipramine treatment and stress [F 1,56 = 4.601, p<0.05] was shown. VGLUT1+/-mice exposed to CMS and treated with saline showed a significant decrease in the discrimination index which was reverted by chronic imipramine treatment ( Figure 5D ).
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Spontaneous motor activity
A significant interaction between genotype and stress [F 1,56 = 5.18, p<0.05] on distance travelled during 30 minutes was shown. CMS induced a significant increase on the distance travelled in VGLUT1+/-mice compared to the control groups ( Figure 6A ).
In addition, no interaction was shown between stress and imipramine treatment.
Interestingly, CMS mice showed a significant increase in motor activity [F 1,56 =7.07, p<0.05]. (Figure 6B ).
Discussion
This study shows that neurotransmitter levels, the expression of presynaptic proteins involved in the glutamate/GABA cycle and different behavioural paradigms related to clinical depression were differentially influenced by both decreased VGLUT1 levels and the chronic mild stress model of depression. Moreover, in VGLUT1+/-mice exposed to chronic mild stress neurochemical and behavioural alterations were found as a result of the interaction between stress and decreased VGLUT1 levels. Specifically, an upregulation of the VGLUT2 transporter in cortical and hippocampal areas was observed, as well as hyperlocomotion, which could be indicative of a glutamatergic overactivation. In addition, these mice manifested an increased vulnerability to anhedonia and helpless behaviour that was fully reverted by chronic imipramine treatment. Summing up, this study shows that reduced levels of VGLUT1 negatively affect behavioural outcome in the presence of adverse environmental conditions and could thus be a potential biological risk factor for major depression.
Regulation of glutamate/GABA cycle and behaviour by reduced VGLUT1
In agreement with our previous study, VGLUT1+/-mice showed normal levels of glutamate but decreased cortical and hippocampal levels of GABA and VGLUT1 as well as helpless behaviour compared to WT (17) . In addition, we found here an increased synthesis of neuronal glutamate ( 
Regulation of glutamate/GABA cycle and behaviour by CMS in WT and VGLUT1+/-mice
In addition to core symptoms of depression, our CMS model (23) also addressed other clinical aspects highly comorbid with major depression such as anxiety (38) and impaired cognition (39, 40) . On the other hand, both depression (3-7) and anxiety (41,42) have been linked to impaired GABAergic function and overactive glutamatergic function has been shown in different anxiety disorders (43, 44) . Other studies have also shown decreased prefrontal cortex and cerebellar GAD65 and GAD67 levels in depressed patients (10, 11) and a link between anxiety and a polymorphism in the GAD65 (45) gene.
Moreover, mice lacking an isoform of GAD65 have shown reduced GABA levels and increased anxiety (46, 47) while rats exposed to CMS show reduced GABA levels, anhedonia and helplessness (48, 49) . We suggest that the downregulation of VGAT and its coupled GABA synthesising enzyme GAD65 in response to CMS could explain the decreased GABA levels observed in the frontal cortex and in the hippocampus of the CMS mice. In addition, a recent study addressing the effects of CMS on glial metabolism, has shown decreased glial GABA formation (49) which is consistent with our results. The upregulation of hippocampal EAAT1 may occur as a neuroprotective response to stressinduced elevations in glutamate in the synaptic cleft (32, 33) as well as in response to increased corticosterone levels (50).
VGLUT1+/-mice exposed to chronic mild stress showed a combined phenotype (stress plus genotype) but also specific neurochemical and behavioural alterations as a result of the interaction between stress and decreased VGLUT1 levels (Table 2) . Interestingly, the striking upregulation of VGLUT2, along with the lack of upregulation of EAAT1 and decreased GABA formation, suggests a glutamatergic overactivation that could be linked to the increased locomotion ( Figure 7 ). Given the segregated distribution of VGLUT1 and VGLUT2 to different synapses and pathways (31) long-loop feedback mechanisms of control could be underlying this interaction. Furthermore, VGLUT1+/-CMS mice showed increased anhedonia and helpless behaviour when compared to WT-CMS and these effects were reverted by repeated imipramine treatment, which further supports the idea that VGLUT1+/-mice are more vulnerable than WT mice to a stress-induced depressivelike phenotype.
This study shows the functional implications of decreased VGLUT1 levels for glutamatergic and GABAergic neurotransmission in the context of behavioural paradigms that model major depression. We propose that decreased VGLUT1 levels may be a biological factor that negatively interacts with well known environmental risk factors of major depression. transporter. CMS induces a downregulation of GAD65 and VGAT that could affect the synthesis and release of GABA in the synaptic terminal. The interaction between CMS and decreased VGLUT1 induces an upregulation of VGLUT2, which along with the lack of upregulation of EAAT1, and decreased inhibitory GABA levels could lead to an increase in the glutamate/GABA ratio and a subsequent increase in motor activity.
